BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36096860)

  • 1. Immunohistochemical staining of LEF-1 is a useful marker for distinguishing WNT-activated medulloblastomas.
    Wang D; Gong J; Zhang H; Liu Y; Sun N; Hao X; Mu K
    Diagn Pathol; 2022 Sep; 17(1):69. PubMed ID: 36096860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
    Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
    J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
    Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
    Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
    Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
    J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization and mutation of beta-catenin in medulloblastomas.
    Eberhart CG; Tihan T; Burger PC
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):333-7. PubMed ID: 10759189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time.
    Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    Goschzik T; Zur Muehlen A; Doerner E; Waha A; Friedrich C; Hau P; Pietsch T
    J Neuropathol Exp Neurol; 2021 Apr; 80(5):419-430. PubMed ID: 33870422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
    Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases.
    Pizem J; Popovic M; Cör A
    J Neurooncol; 2011 Jul; 103(3):459-67. PubMed ID: 20953661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEF-1 immunohistochemistry, a better diagnostic biomarker than β-catenin for medulloblastoma, WNT-activated subtyping.
    Aboubakr O; Métais A; Doz F; Saffroy R; Masliah-Planchon J; Hasty L; Beccaria K; Ayrault O; Dufour C; Varlet P; Tauziède-Espariat A
    J Neuropathol Exp Neurol; 2024 Jan; 83(2):136-138. PubMed ID: 38237134
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative analysis of LEF-1 in odontogenic and salivary tumors.
    Bilodeau EA; Acquafondata M; Barnes EL; Seethala RR
    Hum Pathol; 2015 Feb; 46(2):255-9. PubMed ID: 25497834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
    Tauziède-Espariat A; Huybrechts S; Indersie E; Dufour C; Puget S; Chivet A; Roux A; Pagès M; Gareton A; Chrétien F; Lechapt E; Ayrault O; Varlet P
    Am J Surg Pathol; 2021 Apr; 45(4):558-566. PubMed ID: 33323893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.
    Silva Rd; Marie SK; Uno M; Matushita H; Wakamatsu A; Rosemberg S; Oba-Shinjo SM
    Clinics (Sao Paulo); 2013; 68(2):167-72. PubMed ID: 23525311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles for Xenopus Tcf/Lef genes in mediating specific responses to Wnt/beta-catenin signalling in mesoderm development.
    Liu F; van den Broek O; Destrée O; Hoppler S
    Development; 2005 Dec; 132(24):5375-85. PubMed ID: 16291789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/β-catenin signaling-reporter transgenic zebrafish.
    Shimizu N; Kawakami K; Ishitani T
    Dev Biol; 2012 Oct; 370(1):71-85. PubMed ID: 22842099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification.
    Geng X; Xiao L; Lin GF; Hu R; Wang JH; Rupp RA; Ding X
    FEBS Lett; 2003 Jul; 547(1-3):1-6. PubMed ID: 12860376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.